`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BRECKENRIDGE PHARMACEUTICAL, INC., AND
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED.
`
`Petitioners,
`
`v.
`
`NOVARTIS PHARMACEUTICALS CORPORATION,
`
`Patent Owner.
`
`Case IPR2017-015921
`Patent No. 8,410,131
`
`DECLARATION IN SUPPORT OF PATENT OWNER NOVARTIS’S
`MOTION FOR PRO HAC VICE ADMISSION OF JARED L. STRINGHAM
`UNDER 37 C.F.R. § 42.10
`
`1 IPR2018-00507 has been joined to this proceeding (Paper 29, Apr. 03, 2018)
`
`
`
`1.
`
`I, Jared L. Stringham, am more than twenty-one years of age, am
`
`competent to present this declaration, and have personal knowledge of the facts set
`
`forth herein.
`
`2.
`
`This declaration is given in support of Patent Owner Novartis’s
`
`Motion for Pro Hac Vice Admission of Jared L. Stringham Under 37 C.F.R. §
`
`42.10.
`
`3.
`
`I am an associate at the law firm of Fitzpatrick, Cella, Harper &
`
`Scinto, in the firm’s New York office.
`
`4.
`
`I have been a patent litigation attorney for more than seven years. I
`
`have been litigating patent cases for this entire time period and have been involved
`
`in numerous cases involving patent validity and infringement, at both the District
`
`Court and the Federal Circuit. I have also been involved in inter partes review
`
`proceedings before the Board. A significant portion of my work has involved
`
`biological and chemical arts, with particular emphasis on pharmaceuticals. I am,
`
`therefore, an experienced litigating attorney.
`
`5.
`
`I am a member in good standing of the State Bar of New York. I have
`
`never been suspended or disbarred from practice before any court or administrative
`
`body.
`
`6.
`
`No court or administrative body has ever denied my application for
`
`admission to practice before it.
`
`
`
`7.
`
`No court or administrative body has ever imposed sanctions or
`
`contempt citations on me.
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`9.
`
`I understand that I will be subject to the Office’s Rules of Professional
`
`Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under
`
`37 C.F.R. § 11.19(a).
`
`10.
`
`I have applied to appear pro hac vice in one other proceeding before
`
`the Office in the last three (3) years: Par Pharm. Inc. v. Novartis AG, IPR2016-
`
`00084. I sought and was granted permission to appear pro hac vice in that
`
`proceeding. IPR2016-00084 (Paper 36).
`
`11.
`
`I have an established familiarity with the subject matter at issue in this
`
`proceeding. I have been involved consistently and substantively in the instant
`
`matter since its inception in June 2017. I have read in detail and understand the
`
`Petition filed by Petitioner and the challenged patent, U.S. Patent 8,410,131 (“the
`
`’131 patent”). I have further reviewed the exhibits relied upon by Petitioner in this
`
`proceeding, including each of the references cited in instituted Grounds 1-5.
`
`12.
`
`I have engaged in extensive strategic and substantive discussions
`
`regarding this proceeding with Nicholas N. Kallas, who is the lead counsel for
`
`Patent Owner in this proceeding and a registered practitioner (Reg. No. 31,530).
`
`
`
`13.
`
`Therefore, I have an established familiarity with the subject matter at
`
`issue in this proceeding.
`
`14.
`
`I declare further that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true and further that these statements were made with the knowledge
`
`that willful false statements and the like so made are punishable by fine or
`
`imprisonment, or both, under Section 1001 of Title 18 of the United States Code,
`
`and that such willful false statements may jeopardize the validity of the ' 131
`
`patent.
`
`Dated: July 18,2018
`
` 4%
`
`Jared L. Stringham
`
`